Rtw Investments, LP Alkermes Plc. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Rtw Investments, LP holds 6,884,698 shares of ALKS stock, worth $183 Million. This represents 3.72% of its overall portfolio holdings.
Number of Shares
6,884,698
Previous 7,557,835
8.91%
Holding current value
$183 Million
Previous $217 Million
4.59%
% of portfolio
3.72%
Previous 3.55%
Shares
7 transactions
Others Institutions Holding ALKS
# of Institutions
407Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$774 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$484 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$314 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$213 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.74MShares$153 Million0.3% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.37B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...